Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Falconi

Showing results (21-30 of 635) with videos related to

Pageof 64
Sort By:
Annals of Surgical Oncology|July 11, 2021
ASO Author Reflections: Long-Term Survivors after Upfront Resection for Pancreatic Cancer: Do They Really Exist?Giulio Belfiori, Stefano Crippa, Massimo Falconi
Hepatobiliary Surgery and Nutrition|April 26, 2021
Screening for pancreatic cancer-a compelling challengeGabriele Capurso, Salvatore Paiella, Massimo Falconi
Journal of Hepato-Biliary-Pancreatic Sciences|October 30, 2009
Parenchyma-sparing resections for pancreatic neoplasmsStefano Crippa, Letizia Boninsegna, Stefano Partelli, et al.
Recenti Progressi in Medicina|July 1, 2016
[Pancreatic cancer]Massimo Falconi, Domenico Tamburrino, Elena Buzzetti, et al.
Annals of Surgery|December 6, 2019
Comment on "Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer": What Is Good for the Surgeon Is Just as Good for the Patient?Gianpaolo Balzano, Nicolò Pecorelli, Massimo Falconi, et al.
Annals of Surgical Oncology|June 7, 2022
ASO Author Reflections: The Impact of CT-assessed Liver Steatosis on Postoperative Complications after Pancreaticoduodenectomy for CancerNicolò Pecorelli, Giovanni Guarneri, Diego Palumbo, et al.
Surgery|December 25, 2012
The natural history of a branch-duct intraductal papillary mucinous neoplasm of the pancreasStefano Crippa, Stefano Partelli, Domenico Tamburrino, et al.
Therapeutic Advances in Medical Oncology|February 17, 2018
Somatostatin analogs: is one better than other?Rossana Berardi, Stefano Partelli, Stefano Cascinu, et al.
Annals of Surgical Oncology|September 15, 2020
ASO Author Reflections: Chemopreventive Agents After Pancreatic Resection for Ductal AdenocarcinomaDomenico Tamburrino, Giovanni Guarneri, Gabriele Capurso, et al.
Expert Opinion on Pharmacotherapy|September 29, 2020
Use of octreotide long acting repeatable (LAR) as second-line therapy in advanced neuroendocrine tumors in different clinical settings: an Italian Delphi surveyMassimo Falconi, Nicola Fazio, Diego Ferone, et al.
Pageof 64

Showing results (21-30 of 635) with videos related to

Sort By:
Pageof 64
Annals of Surgical Oncology|July 11, 2021
ASO Author Reflections: Long-Term Survivors after Upfront Resection for Pancreatic Cancer: Do They Really Exist?Giulio Belfiori, Stefano Crippa, Massimo Falconi
Hepatobiliary Surgery and Nutrition|April 26, 2021
Screening for pancreatic cancer-a compelling challengeGabriele Capurso, Salvatore Paiella, Massimo Falconi
Journal of Hepato-Biliary-Pancreatic Sciences|October 30, 2009
Parenchyma-sparing resections for pancreatic neoplasmsStefano Crippa, Letizia Boninsegna, Stefano Partelli, et al.
Recenti Progressi in Medicina|July 1, 2016
[Pancreatic cancer]Massimo Falconi, Domenico Tamburrino, Elena Buzzetti, et al.
Annals of Surgery|December 6, 2019
Comment on "Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer": What Is Good for the Surgeon Is Just as Good for the Patient?Gianpaolo Balzano, Nicolò Pecorelli, Massimo Falconi, et al.
Annals of Surgical Oncology|June 7, 2022
ASO Author Reflections: The Impact of CT-assessed Liver Steatosis on Postoperative Complications after Pancreaticoduodenectomy for CancerNicolò Pecorelli, Giovanni Guarneri, Diego Palumbo, et al.
Surgery|December 25, 2012
The natural history of a branch-duct intraductal papillary mucinous neoplasm of the pancreasStefano Crippa, Stefano Partelli, Domenico Tamburrino, et al.
Therapeutic Advances in Medical Oncology|February 17, 2018
Somatostatin analogs: is one better than other?Rossana Berardi, Stefano Partelli, Stefano Cascinu, et al.
Annals of Surgical Oncology|September 15, 2020
ASO Author Reflections: Chemopreventive Agents After Pancreatic Resection for Ductal AdenocarcinomaDomenico Tamburrino, Giovanni Guarneri, Gabriele Capurso, et al.
Expert Opinion on Pharmacotherapy|September 29, 2020
Use of octreotide long acting repeatable (LAR) as second-line therapy in advanced neuroendocrine tumors in different clinical settings: an Italian Delphi surveyMassimo Falconi, Nicola Fazio, Diego Ferone, et al.
Pageof 64